Zilan Wang

804 total citations
31 papers, 324 citations indexed

About

Zilan Wang is a scholar working on Neurology, Epidemiology and Pathology and Forensic Medicine. According to data from OpenAlex, Zilan Wang has authored 31 papers receiving a total of 324 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Neurology, 12 papers in Epidemiology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Zilan Wang's work include Acute Ischemic Stroke Management (8 papers), Stroke Rehabilitation and Recovery (4 papers) and Multiple Sclerosis Research Studies (4 papers). Zilan Wang is often cited by papers focused on Acute Ischemic Stroke Management (8 papers), Stroke Rehabilitation and Recovery (4 papers) and Multiple Sclerosis Research Studies (4 papers). Zilan Wang collaborates with scholars based in China. Zilan Wang's co-authors include Zhouqing Chen, Zhong Wang, Yanbo Yang, Bixi Gao, Feng Gu, Xiaoxiao Wu, Jiaxuan Li, Yi Ji, Zhong Wang and Tao Xue and has published in prestigious journals such as Frontiers in Immunology, Frontiers in Pharmacology and Frontiers in Neuroscience.

In The Last Decade

Zilan Wang

29 papers receiving 315 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zilan Wang China 10 109 70 64 59 54 31 324
Wen Shao China 11 88 0.8× 42 0.6× 65 1.0× 77 1.3× 75 1.4× 31 389
Bouchra El Moutawakil Morocco 10 124 1.1× 39 0.6× 106 1.7× 45 0.8× 35 0.6× 54 375
Sachiko Hara Japan 9 73 0.7× 99 1.4× 111 1.7× 60 1.0× 140 2.6× 16 437
Yaqing Zhang China 15 48 0.4× 119 1.7× 49 0.8× 58 1.0× 66 1.2× 47 422
Ali Asghar Okhovat Iran 9 122 1.1× 108 1.5× 109 1.7× 48 0.8× 24 0.4× 35 395
Alan J. Tuchman United States 11 83 0.8× 50 0.7× 83 1.3× 50 0.8× 68 1.3× 22 447
Kerstin Bettermann United States 12 55 0.5× 38 0.5× 57 0.9× 16 0.3× 81 1.5× 18 547
Yueli Zhu China 12 75 0.7× 30 0.4× 151 2.4× 21 0.4× 55 1.0× 23 466
Giorgia Iacolino Italy 9 42 0.4× 70 1.0× 88 1.4× 161 2.7× 104 1.9× 10 429
Bo‐Lin Ho Taiwan 11 69 0.6× 50 0.7× 59 0.9× 8 0.1× 68 1.3× 24 374

Countries citing papers authored by Zilan Wang

Since Specialization
Citations

This map shows the geographic impact of Zilan Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zilan Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zilan Wang more than expected).

Fields of papers citing papers by Zilan Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zilan Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zilan Wang. The network helps show where Zilan Wang may publish in the future.

Co-authorship network of co-authors of Zilan Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Zilan Wang. A scholar is included among the top collaborators of Zilan Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zilan Wang. Zilan Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Xue, Tao, Jiaxuan Li, Shujun Chen, et al.. (2023). Different doses of dual orexin receptor antagonists in primary insomnia: a Bayesian network analysis. Frontiers in Pharmacology. 14. 1175372–1175372. 9 indexed citations
2.
Yang, Xingyu, et al.. (2023). Mechanical thrombectomy with intra-arterial alteplase provided better functional outcomes for AIS-LVO: a meta-analysis. Frontiers in Neuroscience. 17. 1137543–1137543. 3 indexed citations
3.
Ji, Yi, Zilan Wang, Xiaoxiao Wu, et al.. (2023). The FDA-approved anti-amyloid-β monoclonal antibodies for the treatment of Alzheimer’s disease: a systematic review and meta-analysis of randomized controlled trials. European journal of medical research. 28(1). 544–544. 68 indexed citations
4.
Yin, Minyue, Xiaolong Liang, Zilan Wang, et al.. (2023). Identification of Asymptomatic COVID-19 Patients on Chest CT Images Using Transformer-Based or Convolutional Neural Network–Based Deep Learning Models. Journal of Digital Imaging. 36(3). 827–836. 5 indexed citations
5.
Wang, Zilan, Xiaoxiao Wu, Xingyu Yang, et al.. (2022). Efficacy and safety of recanalization therapy for acute ischemic stroke with COVID-19: A systematic review and meta-analysis. Frontiers in Neurology. 13. 984135–984135. 2 indexed citations
6.
Gu, Feng, Xingyu Yang, Zilan Wang, et al.. (2022). Diagnostic accuracy of intraoperative brainstem auditory evoked potential for predicting hearing loss after vestibular schwannoma surgery. Frontiers in Neurology. 13. 1018324–1018324. 1 indexed citations
7.
Gu, Feng, Xiaoxiao Wu, Zilan Wang, et al.. (2022). Performance of deep learning in the detection of intracranial aneurysm: A systematic review and meta-analysis. European Journal of Radiology. 155. 110457–110457. 12 indexed citations
8.
9.
Liu, Guangjie, Xingyu Yang, Tao Xue, et al.. (2021). Is Fluoxetine Good for Subacute Stroke? A Meta-Analysis Evidenced From Randomized Controlled Trials. Frontiers in Neurology. 12. 633781–633781. 9 indexed citations
10.
11.
Xue, Tao, Ruming Deng, Bixi Gao, et al.. (2021). Intraoperative indocyanine green video angiography (ICG–VA) with FLOW 800 software in complex intracranial aneurysm surgery. Chinese Neurosurgical Journal. 7(1). 28–28. 6 indexed citations
12.
Gao, Bixi, Tao Xue, Yanbo Yang, et al.. (2020). Tranexamic Acid Inhibits Hematoma Expansion in Intracerebral Hemorrhage and Traumatic Brain Injury. Does Blood Pressure Play a Potential Role? A Meta-Analysis from Randmized Controlled Trials. Journal of Stroke and Cerebrovascular Diseases. 30(1). 105436–105436. 10 indexed citations
13.
Xue, Tao, Jiahao Yu, Shujun Chen, et al.. (2020). Different Targets of Monoclonal Antibodies in Neuromyelitis Optica Spectrum Disorders: A Meta-Analysis Evidenced From Randomized Controlled Trials. Frontiers in Neurology. 11. 604445–604445. 4 indexed citations
14.
Wang, Zilan, Yanbo Yang, Xiaolong Liang, et al.. (2020). COVID-19 Associated Ischemic Stroke and Hemorrhagic Stroke: Incidence, Potential Pathological Mechanism, and Management. Frontiers in Neurology. 11. 571996–571996. 58 indexed citations
15.
Gao, Bixi, et al.. (2020). Efficacy and Safety of Rimegepant for the Acute Treatment of Migraine: Evidence From Randomized Controlled Trials. Frontiers in Pharmacology. 10. 1577–1577. 34 indexed citations
16.
Sun, Yue, Yanbo Yang, Zilan Wang, et al.. (2020). Ozanimod for Treatment of Relapsing-Remitting Multiple Sclerosis in Adults: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Frontiers in Pharmacology. 11. 589146–589146. 8 indexed citations
17.
Wang, Zilan, Xiaolong Liang, Yanbo Yang, et al.. (2020). A new scoring system for predicting extent of resection in medial sphenoid wing meningiomas based on three-dimensional multimodality fusion imaging. Chinese Neurosurgical Journal. 6(1). 35–35. 2 indexed citations
18.
Yang, Yanbo, Zilan Wang, Bixi Gao, et al.. (2020). Different doses of galcanezumab versus placebo in patients with migraine and cluster headache: a meta-analysis of randomized controlled trials. The Journal of Headache and Pain. 21(1). 14–14. 11 indexed citations
19.
Gao, Bixi, Rong Wan, Zilan Wang, et al.. (2020). Monthly versus quarterly fremanezumab for the prevention of migraine: a systemic review and meta-analysis from randomized controlled trials. Naunyn-Schmiedeberg s Archives of Pharmacology. 394(4). 819–828. 3 indexed citations
20.
Yang, Yanbo, Yue Sun, Bixi Gao, et al.. (2020). Lasmiditan for Acute Treatment of Migraine in Adults: A Systematic Review and Meta-analysis of Randomized Controlled Trials. CNS Drugs. 34(10). 1015–1024. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wen Shao Breakdown of academic impact, for papers by Bouchra El Moutawakil Breakdown of academic impact, for papers by Sachiko Hara Breakdown of academic impact, for papers by Yaqing Zhang Breakdown of academic impact, for papers by Ali Asghar Okhovat Breakdown of academic impact, for papers by Alan J. Tuchman Breakdown of academic impact, for papers by Kerstin Bettermann Breakdown of academic impact, for papers by Yueli Zhu Breakdown of academic impact, for papers by Giorgia Iacolino Breakdown of academic impact, for papers by Bo‐Lin Ho
Rankless by CCL
2026